Drug Shortage Report for TAZORAC

Last updated on 2019-05-18 History
Report ID 65978
Drug Identification Number 02230784
Brand name TAZORAC
Common or Proper name Tazorac
Company Name ALLERGAN INC
Active Ingredient(s) TAZAROTENE
Strength(s) 0.05%
Dosage form(s) GEL
Route of administration TOPICAL
Packaging size 30 gram
ATC code D05AX
ATC description ANTIPSORIATICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-10-31
Actual start date 2018-10-31
Estimated end date 2019-05-17
Actual end date 2019-05-17
Shortage status Resolved
Updated date 2019-05-18
Company comments Production issue
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-05-18 English Compare
v2 2018-11-01 French Compare
v1 2018-11-01 English Compare